An Investigational Drug in Patients with Osteoarthritis - Article Degenerative Joint Disease; Osteoarthritis arthritis
Clinical Trial: An Investigational Drug in Patients with Osteoarthritis
This study is no longer recruiting patients.
This study was conducted to assess the safety and tolerability of an investigational drug and to evaluate its effectiveness in the treatment of osteoarthritis of the hip or knee in both men and women.
|Condition||Treatment or Intervention||Phase|
|Osteoarthritis || ||Phase II |
MedlinePlus related topics: Osteoarthritis
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Parallel Assignment, Safety/Efficacy Study
Ages Eligible for Study: 40 Years and above, Genders Eligible for Study: Both
- Patients with osteoarthritis of the hip or knee who use current approved medication (nonsteroidal anti-inflammatory drugs (NSAIDs)) or tylenol to treat the symptoms of their osteoarthritis. Patients taking NSAIDs are required to discontinue using these drugs and their symptoms must become worse.
- Patients with certain medical conditions may not be allowed to participate. These conditions will be reviewed with the study physician.
Call for Information, Horsham, Pennsylvania, 19044, United States
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: September 23, 2004
ClinicalTrials.gov Identifier: NCT00092755
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Cache Date: April 9, 2005